(Q34181796)

31 July 2017

1 reference

title

Current treatment practice in immunosuppression (English)

1 reference

31 July 2017

1 reference

Ciancio G

1

1 reference

31 July 2017

Burke GW

series ordinal

2

1 reference

31 July 2017

Miller J

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

1307-1330

1 reference

Cyclosporin A in patients receiving renal allografts from cadaver donors

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

The mechanism of action of cyclosporin A and FK506.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Experience With 100 Consecutive Simultaneous Kidney-Pancreas Transplants With Bladder Drainage

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

FK 506 for liver, kidney, and pancreas transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A Comparison of Tacrolimus (FK 506) and Cyclosporine for Immunosuppression in Liver Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Efficacy of tacrolimus in patients with steroid-resistant cardiac allograft cellular rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

FK 506 and mycophenolate mofetil in renal transplant recipients: six-month results of a multicenter, randomized dose ranging trial. FK 506 MMF Dose-Ranging Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Clinical intestinal transplantation: experience in Miami

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Target of rapamycin proteins and their kinase activities are required for meiosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Analysis of functional renal allograft tolerance with single-dose rapamycin based induction immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Rapamycin inhibits vascular smooth muscle cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A phase I study of a 4-week course of SDZ-RAD (RAD) quiescent cyclosporine-prednisone-treated renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

An update on new immunosuppressive drugs undergoing preclinical and clinical trials: potential applications in organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Weaning of immunosuppression in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A humanized antibody that binds to the interleukin 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Rescue therapy with interleukin-2 receptor antibody in high risk kidney transplant patients: a 3-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Induction of tolerance to small bowel allografts in high-responder rats by combining anti-CD4 with CTLA4Ig

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Neutrophil induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18-ICAM-1 adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Regulation of intercellular adhesion molecule-1 (ICAM-1) in ischemic and reperfused canine myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

ICAM-1 affects reperfusion injury and graft function after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

ICAM-1 antisense oligodesoxynucleotides prevent reperfusion injury and enhance immediate graft function in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Expression of Flt3-ligand by the endothelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Striking augmentation of hematopoietic cell chimerism in noncytoablated allogeneic bone marrow recipients by FLT3 ligand and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Mixed chimerism to induce tolerance for solid organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Mechanisms of transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

The lost chord: microchimerism and allograft survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Actively acquired tolerance of foreign cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Chimerism and transplantation tolerance: cause and effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

The human bone marrow as an immunoregulatory organ

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Long-term prognosis of renal transplantation after preemptive treatment of cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

A BLINDED, RANDOMIZED CLINICAL TRIAL OF MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN CADAVERIC RENAL TRANSPLANTATION1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Evidence that Thrombin-stimulated DNA Synthesis in Pulmonary Arterial Fibroblasts Involves Phosphatidylinositol 3-kinase-dependent p70 Ribosomal S6 Kinase Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Morphological and functional changes in small-bowel allografts of pigs under combined tacrolimus and mycophenolate mofetil immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.7.1307

10.1517/14656566.1.7.1307

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference